Theratechnologies Profit Margin vs. Current Valuation

TH Stock  CAD 2.33  0.12  5.43%   
Based on Theratechnologies' profitability indicators, Theratechnologies' profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Theratechnologies' ability to earn profits and add value for shareholders.

Theratechnologies Net Profit Margin

(0.26)

As of the 18th of December 2024, Sales General And Administrative To Revenue is likely to grow to 0.34, while Price To Sales Ratio is likely to drop 0.56. At this time, Theratechnologies' Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 18th of December 2024, Income Tax Expense is likely to grow to about 508.4 K, while Operating Income is likely to drop (10 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.960.87
Significantly Up
Slightly volatile
For Theratechnologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Theratechnologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Theratechnologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Theratechnologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Theratechnologies over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Theratechnologies Current Valuation vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Theratechnologies's current stock value. Our valuation model uses many indicators to compare Theratechnologies value to that of its competitors to determine the firm's financial worth.
Theratechnologies is currently regarded as top stock in profit margin category among its peers. It also is currently regarded number one company in current valuation category among its peers . At this time, Theratechnologies' Net Loss is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Theratechnologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Theratechnologies' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Theratechnologies Current Valuation vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Theratechnologies

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.04) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Theratechnologies

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
134.15 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Theratechnologies Current Valuation vs Competition

Theratechnologies is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about (1.16 Trillion). Theratechnologies adds roughly 134.15 Million in current valuation claiming only tiny portion of equities under Health Care industry.

Theratechnologies Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Theratechnologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Theratechnologies will eventually generate negative long term returns. The profitability progress is the general direction of Theratechnologies' change in net profit over the period of time. It can combine multiple indicators of Theratechnologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income786.6 K825.9 K
Operating Income-9.6 M-10 M
Income Before Tax-21.2 M-20.1 M
Total Other Income Expense Net-11.6 M-11 M
Net Loss-21.6 M-20.5 M
Income Tax Expense484.1 K508.4 K
Net Loss-21.6 M-22.6 M
Net Loss-42.5 M-40.4 M
Interest Income884.4 K840.1 K
Net Interest Income-9.5 M-9.1 M
Change To Netincome8.1 M8.5 M
Net Loss(1.05)(0.99)
Income Quality 0.21  0.20 
Net Income Per E B T 1.17  1.09 

Theratechnologies Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Theratechnologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Theratechnologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Theratechnologies' important profitability drivers and their relationship over time.

Use Theratechnologies in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.

Theratechnologies Pair Trading

Theratechnologies Pair Trading Analysis

The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.
The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Theratechnologies position

In addition to having Theratechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:
Check out World Market Map.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
To fully project Theratechnologies' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Theratechnologies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Theratechnologies' income statement, its balance sheet, and the statement of cash flows.
Potential Theratechnologies investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Theratechnologies investors may work on each financial statement separately, they are all related. The changes in Theratechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Theratechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.